GenBioPro & Joe Biden

GenBioPro: GenBioPro, a manufacturer of a generic version of mifepristone, also received temporary relief from Samuel Alito's order. The company appealed to the United States — Supreme Court of the United States, stating that the 5th Circuit's decision 'unleashed regulatory chaos' and threatened access to mifepristone nationwide.

Joe Biden: The Biden administration permanently eliminated the in-person mandate for mifepristone in December 2021, a decision that enabled abortion rights groups to make abortion pills accessible in every state despite Roe's end.

GenBioPro: GenBioPro, a generic Mifepristone manufacturer, stated that the court's decision ignores the United States — Food and Drug Administration's science and decades of safe use of the drug.

Joe Biden: Rules finalized under President Joe Biden that ended the in-person requirement for mifepristone were reversed by the appellate court, putting his administration's policy on abortion access under scrutiny.